Phocas Financial Corp. Agenus Inc Transaction History

Phocas Financial Corp.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 13, 2019	SELL	$2.51 - $3.73 $7,529 - $11,190	-3,000 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.59 - $2.66 $4,770 - $7,980	3,000 New	3,000 $7,000

128

205M

1.18M

69.8K

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.